INNOPHARMAX is a specialty pharmaceutical company focused in the development and commercialization of products for the treatment of infectious diseases, immunology and oncology. We internally develop and/or acquire potential drug candidates for further clinical development as well as commercialization. We intend to use internally developed drug delivery technology platforms for improving the safety and effectiveness of currently available drugs and providing better medical choices in these specific disease categories. Based on strong formulation techniques and unique global partnership strategy, we commit to deliver superior products cost-effectively with global quality standards to meet patients’ needs.